Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Artivion, Inc. - SIC # 8099 - HEALTH AND ALLIED SERVICES, NOT ELSEWHERE CLASSIFIED
Ticker
Exchange
SIC #
Website
Latest Ticker
AORT
New York
8099
artivion.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Artivion, Inc.
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results
- Apr 21st, 2025 8:10 pm
Investors in Artivion (NYSE:AORT) have seen returns of 15% over the past year
- Apr 14th, 2025 12:58 pm
Do Options Traders Know Something About Artivion (AORT) Stock We Don't?
- Mar 24th, 2025 4:20 pm
Artivion to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
- Mar 4th, 2025 9:05 pm
Artivion Full Year 2024 Earnings: EPS Misses Expectations
- Mar 4th, 2025 10:31 am
Down -18.58% in 4 Weeks, Here's Why Artivion (AORT) Looks Ripe for a Turnaround
- Feb 27th, 2025 2:35 pm
Earnings Miss: Artivion, Inc. Missed EPS And Analysts Are Revising Their Forecasts
- Feb 27th, 2025 10:54 am
Artivion price target lowered to $32 from $34 at Needham
- Feb 26th, 2025 3:01 pm
Artivion Reports Fourth Quarter and Full Year 2024 Financial Results
- Feb 24th, 2025 9:05 pm
Should You Investigate Artivion, Inc. (NYSE:AORT) At US$28.26?
- Feb 24th, 2025 5:22 pm
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2024 Financial Results
- Feb 10th, 2025 9:10 pm
Estimating The Fair Value Of Artivion, Inc. (NYSE:AORT)
- Feb 4th, 2025 10:17 am
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual Meeting
- Jan 27th, 2025 1:00 pm
3 US Stocks Estimated To Be Trading Below Their Intrinsic Value In January 2025
- Jan 14th, 2025 2:03 pm
Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis
- Dec 9th, 2024 1:00 pm
Returns On Capital Are Showing Encouraging Signs At Artivion (NYSE:AORT)
- Nov 30th, 2024 2:08 pm
Artivion Third Quarter 2024 Earnings: Beats Expectations
- Nov 9th, 2024 12:03 pm
Artivion Reports Third Quarter 2024 Financial Results
- Nov 7th, 2024 9:05 pm
Artivion to Participate in Upcoming Investor Conferences
- Nov 5th, 2024 9:15 pm
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results
- Oct 24th, 2024 8:15 pm
Scroll